The State Key Laboratory of Chemical Engineering, Department of Chemical Engineering, Tsinghua University, Beijing 100084, China.
Department of Biomedical Engineering, School of Medicine, Tsinghua-Peking Center for Life Sciences Tsinghua University, Beijing 100084, China.
Biosensors (Basel). 2022 Aug 19;12(8):659. doi: 10.3390/bios12080659.
Cell encapsulation has been widely employed in cell therapy, characterization, and analysis, as well as many other biomedical applications. While droplet-based microfluidic technology is advantageous in cell microencapsulation because of its modularity, controllability, mild conditions, and easy operation when compared to other state-of-art methods, it faces the dilemma between high throughput and monodispersity of generated cell-laden microdroplets. In addition, the lack of a biocompatible method of de-emulsification transferring cell-laden hydrogel from cytotoxic oil phase into cell culture medium also hurtles the practical application of microfluidic technology. Here, a novel step-T-junction microchannel was employed to encapsulate cells into monodisperse microspheres at the high-throughput jetting regime. An alginate-gelatin co-polymer system was employed to enable the microfluidic-based fabrication of cell-laden microgels with mild cross-linking conditions and great biocompatibility, notably for the process of de-emulsification. The mechanical properties of alginate-gelatin hydrogel, e.g., stiffness, stress-relaxation, and viscoelasticity, are fully adjustable in offering a 3D biomechanical microenvironment that is optimal for the specific encapsulated cell type. Finally, the encapsulation of HepG2 cells into monodisperse alginate-gelatin microgels with the novel microfluidic system and the subsequent cultivation proved the maintenance of the long-term viability, proliferation, and functionalities of encapsulated cells, indicating the promising potential of the as-designed system in tissue engineering and regenerative medicine.
细胞包封已广泛应用于细胞治疗、表征和分析,以及许多其他生物医学应用。与其他最先进的方法相比,基于液滴的微流控技术在细胞微封装方面具有优势,因为它具有模块化、可控性、温和的条件和易于操作,但它面临着生成的载细胞微滴的高通量和单分散性之间的困境。此外,缺乏将载细胞水凝胶从细胞毒性油相转移到细胞培养基中的生物相容的去乳化方法也阻碍了微流控技术的实际应用。在这里,采用了一种新颖的阶梯 T 型微通道,在高通量射流状态下将细胞包封成单分散的微球。采用海藻酸钠-明胶共聚物体系,能够实现基于微流控的载细胞微凝胶的温和交联条件和良好的生物相容性,特别是在去乳化过程中。海藻酸钠-明胶水凝胶的机械性能,如硬度、应力松弛和粘弹性,可以完全调节,提供最佳的 3D 生物力学微环境,适用于特定封装的细胞类型。最后,用新型微流控系统将 HepG2 细胞包封成单分散的海藻酸钠-明胶微凝胶,并随后进行培养,证明了封装细胞的长期活力、增殖和功能得以维持,表明该设计系统在组织工程和再生医学方面具有广阔的应用前景。